Deciphering Drug Targets for Alzheimer’s Disease / edited by Dileep Kumar, Vaishali M. Patil, Dee Wu, Nanasaheb Thorat
Chapter 1.Deciphering New Drug Targets in Alzheimer’s Disease -- Chapter 2. Novel Therapeutic Targets for Treating Alzheimer’s Disease -- Chapter 3. Modified Investigation Tools and Techniques Useful in Alzheimer’s Disease Research -- Chapter 4. Dual Specificity Tyrosine Phosphorylation Regulated Kinase1A (DYRK1A) Inhibitors: The Quest for a Disease-Modifying Treatment for Alzheimer’s Disease -- Chapter 5. β-secretase as a primary drug target of Alzheimer disease: Function, Structure, and Inhibition -- Chapter 6. Endocrine Receptors: The Potential Therapeutic Targets for Alzheimer’s -- Chapter 7. Calcium Channels as a Potential Therapeutic Target for Alzheimer’s Disease -- Chapter 8. Traversing Through the Trajectory of Pathogenic Astrocytes in Alzheimer’s Disease -- Chapter 9. Targeting Mitochondrial Dynamics as a Restorative Approach in the Treatment of Alzheimer’s Disease -- Chapter 10. Epigenetic Therapy for Alzheimer’s Disease -- Chapter 11. Exploring the Diverse Roles of GSK-3ß Kinase in Alzheimer’s Disease -- Chapter 12. Role of Target Fishing in Discovery of Novel Anti-Alzheimer’s Agents: In Silico Applications -- Chapter 13. Multi-Target Directed Ligand Approach in Anti-Alzheimer’s Drug Discovery -- Chapter 14. Investigating the Role of Tau Proteins in Alzheimer’s Disease-From Typical Functioning MAPs to Aberrant Fibrillary Deposits in the Brain -- Chapter 15. The Overview of Drugs Used in Alzheimer’s Disease and Their Molecular Targets..
This book explains the fundamental characteristics and biofunctionality of Alzheimer’s Disease drug targets and provides up-to-date information on the full range of their biomedical applications. An introductory section gives an overview of the recent developments related to drug targets identified and studied related to Alzheimer’s Disease and key developments from preclinical and clinical studies focusing on various molecular targets related to AD and dementia by subject experts all around the globe. Here, individual chapters address the progress and perspectives in human and non-human research, role of various biomarkers as an overview, advanced gene therapy, and novel compounds for therapeutic targets for Alzheimer’s disease. The book will be essential reading for graduate students, scientists, and engineers in any of the biomedical research fields in which efforts are being made to utilize novel drug targets and develop effective strategies for new drug targeting and delivery in Alzheimer’s disease treatment..
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
2023. |
|---|---|
| Erschienen: |
Singapore: Springer Nature Singapore ; 2023. Singapore: Imprint: Springer ; 2023. |
| Ausgabe: |
1st ed. 2023. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kumar, Dileep [HerausgeberIn] |
|---|
| Links: |
doi.org [lizenzpflichtig] |
|---|
| ISBN: |
|---|
| Themen: |
Biology |
|---|
| Umfang: |
1 Online-Ressource(XV, 381 p. 1 illus.) |
|---|
| doi: |
10.1007/978-981-99-2657-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
1858792525 |
|---|
| LEADER | 01000nam a22002652 4500 | ||
|---|---|---|---|
| 001 | 1858792525 | ||
| 003 | DE-627 | ||
| 005 | 20230905111501.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230905s2023 si |||||o 00| ||eng c | ||
| 020 | |a 9789819926572 |9 978-981-99-2657-2 | ||
| 024 | 7 | |a 10.1007/978-981-99-2657-2 |2 doi | |
| 035 | |a (DE-627)1858792525 | ||
| 035 | |a (DE-599)KEP095816100 | ||
| 035 | |a (DE-He213)978-981-99-2657-2 | ||
| 035 | |a (EBP)095816100 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XB-SG | ||
| 072 | 7 | |a MBGR |2 bicssc | |
| 072 | 7 | |a MED000000 |2 bisacsh | |
| 245 | 1 | 0 | |a Deciphering Drug Targets for Alzheimer’s Disease |c edited by Dileep Kumar, Vaishali M. Patil, Dee Wu, Nanasaheb Thorat |
| 250 | |a 1st ed. 2023. | ||
| 264 | 1 | |a Singapore |b Springer Nature Singapore |c 2023. | |
| 264 | 1 | |a Singapore |b Imprint: Springer |c 2023. | |
| 300 | |a 1 Online-Ressource(XV, 381 p. 1 illus.) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Chapter 1.Deciphering New Drug Targets in Alzheimer’s Disease -- Chapter 2. Novel Therapeutic Targets for Treating Alzheimer’s Disease -- Chapter 3. Modified Investigation Tools and Techniques Useful in Alzheimer’s Disease Research -- Chapter 4. Dual Specificity Tyrosine Phosphorylation Regulated Kinase1A (DYRK1A) Inhibitors: The Quest for a Disease-Modifying Treatment for Alzheimer’s Disease -- Chapter 5. β-secretase as a primary drug target of Alzheimer disease: Function, Structure, and Inhibition -- Chapter 6. Endocrine Receptors: The Potential Therapeutic Targets for Alzheimer’s -- Chapter 7. Calcium Channels as a Potential Therapeutic Target for Alzheimer’s Disease -- Chapter 8. Traversing Through the Trajectory of Pathogenic Astrocytes in Alzheimer’s Disease -- Chapter 9. Targeting Mitochondrial Dynamics as a Restorative Approach in the Treatment of Alzheimer’s Disease -- Chapter 10. Epigenetic Therapy for Alzheimer’s Disease -- Chapter 11. Exploring the Diverse Roles of GSK-3ß Kinase in Alzheimer’s Disease -- Chapter 12. Role of Target Fishing in Discovery of Novel Anti-Alzheimer’s Agents: In Silico Applications -- Chapter 13. Multi-Target Directed Ligand Approach in Anti-Alzheimer’s Drug Discovery -- Chapter 14. Investigating the Role of Tau Proteins in Alzheimer’s Disease-From Typical Functioning MAPs to Aberrant Fibrillary Deposits in the Brain -- Chapter 15. The Overview of Drugs Used in Alzheimer’s Disease and Their Molecular Targets. | ||
| 520 | |a This book explains the fundamental characteristics and biofunctionality of Alzheimer’s Disease drug targets and provides up-to-date information on the full range of their biomedical applications. An introductory section gives an overview of the recent developments related to drug targets identified and studied related to Alzheimer’s Disease and key developments from preclinical and clinical studies focusing on various molecular targets related to AD and dementia by subject experts all around the globe. Here, individual chapters address the progress and perspectives in human and non-human research, role of various biomarkers as an overview, advanced gene therapy, and novel compounds for therapeutic targets for Alzheimer’s disease. The book will be essential reading for graduate students, scientists, and engineers in any of the biomedical research fields in which efforts are being made to utilize novel drug targets and develop effective strategies for new drug targeting and delivery in Alzheimer’s disease treatment. | ||
| 650 | 0 | |a Medicine | |
| 650 | 0 | |a Biology | |
| 650 | 0 | |a Biology. | |
| 650 | 0 | |a Neurosciences. | |
| 650 | 0 | |a Biotechnology. | |
| 650 | 0 | |a Drug delivery systems. | |
| 700 | 1 | |a Kumar, Dileep |e herausgeberin |4 edt | |
| 700 | 1 | |a Patil, Vaishali M. |e herausgeberin |4 edt | |
| 700 | 1 | |a Wu, Dee |e herausgeberin |4 edt | |
| 700 | 1 | |a Thorat, Nanasaheb |e herausgeberin |4 edt | |
| 776 | 1 | |z 9789819926565 | |
| 776 | 1 | |z 9789819926589 | |
| 776 | 1 | |z 9789819926596 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789819926565 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789819926589 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789819926596 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-981-99-2657-2 |m X:SPRINGER |x Resolving-System |z lizenzpflichtig |
| 912 | |a ZDB-2-SEB |b 2023 | ||
| 912 | |a ZDB-2-SBL |b 2023 | ||
| 912 | |a ZDB-2-SXB |b 2023 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a ISIL_DE-18 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a GBV_ILN_22_i06404 | ||
| 912 | |a GBV_ILN_23 | ||
| 912 | |a ISIL_DE-830 | ||
| 912 | |a GBV_ILN_34 | ||
| 912 | |a ISIL_DE-18-302 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a ISIL_DE-28 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a ISIL_DE-3 | ||
| 912 | |a GBV_ILN_100 | ||
| 912 | |a ISIL_DE-Ma9 | ||
| 912 | |a GBV_ILN_101 | ||
| 912 | |a ISIL_DE-Ma14 | ||
| 912 | |a GBV_ILN_120 | ||
| 912 | |a ISIL_DE-715 | ||
| 912 | |a GBV_ILN_130 | ||
| 912 | |a ISIL_DE-700 | ||
| 912 | |a GBV_ILN_132 | ||
| 912 | |a ISIL_DE-959 | ||
| 912 | |a GBV_ILN_186 | ||
| 912 | |a ISIL_DE-519 | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a ISIL_DE-517 | ||
| 912 | |a GBV_ILN_381 | ||
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a ISIL_DE-25 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a ISIL_DE-14 | ||
| 912 | |a GBV_ILN_2010 | ||
| 912 | |a ISIL_DE-15 | ||
| 912 | |a GBV_ILN_2014 | ||
| 912 | |a ISIL_DE-90 | ||
| 912 | |a GBV_ILN_2015 | ||
| 912 | |a ISIL_DE-93 | ||
| 912 | |a GBV_ILN_2017 | ||
| 912 | |a ISIL_DE-576 | ||
| 912 | |a GBV_ILN_2068 | ||
| 912 | |a ISIL_DE-Fn1 | ||
| 912 | |a GBV_ILN_2108 | ||
| 912 | |a ISIL_DE-991 | ||
| 912 | |a GBV_ILN_2119 | ||
| 912 | |a ISIL_DE-943 | ||
| 912 | |a GBV_ILN_2129 | ||
| 912 | |a ISIL_DE-Ofb1 | ||
| 951 | |a BO | ||
| 953 | |2 045F |a 610.72 | ||
| 980 | |2 22 |1 01 |x 0018 |b 4373875375 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |h h64 Springer Biomedical |k Campuslizenz Universität Hamburg. - Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y zi06404 |z 08-09-23 | ||
| 980 | |2 23 |1 01 |x 0830 |b 4373889252 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |h olr-springer |u i |y z |z 08-09-23 | ||
| 980 | |2 34 |1 01 |x 3551 |b 4373849978 |h OLR-SEB-SBL |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y zi002 |z 08-09-23 | ||
| 980 | |2 62 |1 01 |x 0028 |b 4373930449 |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 08-09-23 | ||
| 980 | |2 65 |1 01 |x 0003 |b 4373945160 |c 03 |f --%%-- |d ebook |e --%%-- |j --%%-- |h OLR-SEB-ZDB-2-SBL |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. |y k3o |z 08-09-23 | ||
| 980 | |2 100 |1 01 |x 3100 |b 4373906084 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |c 09 |f --%%-- |d eBook Springer |e --%%-- |j --%%-- |h OLR-SEB |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 08-09-23 | ||
| 980 | |2 101 |1 01 |x 3101 |b 4373915415 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |c 09 |f --%%-- |d eBook Springer |e --%%-- |j --%%-- |h OLR-SEB |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 08-09-23 | ||
| 980 | |2 120 |1 01 |x 0715 |b 4399388455 |c 00 |f --%%-- |d --%%-- |e g |j --%%-- |h alma |y z |z 28-10-23 | ||
| 980 | |2 130 |1 01 |x 0700 |b 4373922489 |h OLR-SEB |k Vervielfältigungen (z. B. Kopien, Downloads) nur für den eigenen wissenschaftlichen Gebrauch. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots |y z |z 08-09-23 | ||
| 980 | |2 132 |1 01 |x 0959 |b 4373814791 |h OLR-ESP-SBL |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y k |z 08-09-23 | ||
| 980 | |2 186 |1 01 |x 0519 |b 4373862265 |h OLR-SEB |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 08-09-23 | ||
| 980 | |2 285 |1 01 |x 0517 |b 4373926050 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |h OLR-ESP-SBL |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 08-09-23 | ||
| 980 | |2 381 |1 01 |x 4381 |b 4373847991 |h OLR-SEB |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots |y z |z 08-09-23 | ||
| 980 | |2 2003 |1 01 |x DE-25 |b 4372811179 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Universitätslizenz |y l01 |z 05-09-23 | ||
| 980 | |2 2006 |1 01 |x DE-14 |b 4372851278 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 05-09-23 | ||
| 980 | |2 2010 |1 01 |x DE-15 |b 4372851294 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Campuslizenz |y l01 |z 05-09-23 | ||
| 980 | |2 2014 |1 01 |x DE-90 |b 4372851308 |c 00 |f --%%-- |d --%%-- |e --%%-- |j kp |y l01 |z 05-09-23 | ||
| 980 | |2 2015 |1 01 |x DE-93 |b 4372851316 |c 00 |f --%%-- |d --%%-- |e p |j --%%-- |k Campuslizenz |y l01 |z 05-09-23 | ||
| 980 | |2 2017 |1 01 |x DE-576 |b 4372851324 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Besitznachweis BSZ nur für Dateneinspielung, keine echte Lizenz vorhanden |y l01 |z 05-09-23 | ||
| 980 | |2 2068 |1 01 |x DE-Fn1 |b 4372811187 |c 00 |f --%%-- |d eBook Springer |e --%%-- |j en |y l01 |z 05-09-23 | ||
| 980 | |2 2108 |1 01 |x DE-991 |b 4372811195 |c 00 |f --%%-- |d eBook Springer |e --%%-- |j kp |k Elektronischer Volltext - Campuslizenz |y l01 |z 05-09-23 | ||
| 980 | |2 2119 |1 01 |x DE-943 |b 4372811209 |c 00 |f --%%-- |d eBook Springer |e --%%-- |j n |k Elektronischer Volltext - Campuslizenz |y l01 |z 05-09-23 | ||
| 980 | |2 2129 |1 01 |x DE-Ofb1 |b 4511788731 |c 00 |f --%%-- |d E-Book Springer |e --%%-- |j n |y l01 |z 15-04-24 | ||
| 981 | |2 22 |1 01 |x 0018 |y Volltextzugang |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 22 |1 01 |x 0018 |y Nur für Angehörige der Universität Hamburg: Volltextzugang von außerhalb des Campus |r http://emedien.sub.uni-hamburg.de/han/SpringerEbooksUKE/doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 23 |1 01 |x 0830 |y Springer EBook |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 34 |1 01 |x 3551 |y Zugriff nur im dem Netz der HAW-Hamburg |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 62 |1 01 |x 0028 |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 65 |1 01 |x 0003 |y Volltextzugang Campus |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 100 |1 01 |x 3100 |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 100 |1 01 |x 3100 |y für Uniangehörige: Zugang weltweit |r https://han.med.uni-magdeburg.de/han/SPR-eBook-BiomedicalandLifeScience-einzeln/doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 101 |1 01 |x 3101 |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 101 |1 01 |x 3101 |y für Uniangehörige: Zugang weltweit |r https://han.med.uni-magdeburg.de/han/SPR-eBook-BiomedicalandLifeScience-einzeln/doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 120 |1 01 |x 0715 |r http://49gbv-uob-primo.hosted.exlibrisgroup.com/openurl/49GBV_UOB/UOB_services_page?u.ignore_date_coverage=true&rft.mms_id=991016291667103501 | ||
| 981 | |2 130 |1 01 |x 0700 |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 132 |1 01 |x 0959 |y Zugriff nur für Angehörige der Hochschule Osnabrück im Hochschulnetz |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 186 |1 01 |x 0519 |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 285 |1 01 |x 0517 |y E-books (Springer) |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 381 |1 01 |x 4381 |y Zugriff nur für GEOMAR-Mitarbeiter / Access for GEOMAR employees only |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 2003 |1 01 |x DE-25 |r https://www.redi-bw.de/start/unifr/EBooks-springer/10.1007/978-981-99-2657-2 | ||
| 981 | |2 2006 |1 01 |x DE-14 |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 2010 |1 01 |x DE-15 |y Online-Zugriff |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 2014 |1 01 |x DE-90 |y Zugang im Netz des KIT |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 2015 |1 01 |x DE-93 |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 2068 |1 01 |x DE-Fn1 |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 2108 |1 01 |x DE-991 |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 2119 |1 01 |x DE-943 |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 981 | |2 2129 |1 01 |x DE-Ofb1 |r https://doi.org/10.1007/978-981-99-2657-2 | ||
| 982 | |2 132 |1 01 |x 0959 |8 00 |a EBooks Springer Biomedical and Life Sciences | ||
| 985 | |2 22 |1 01 |x 0018 |a h64 ebook | ||
| 995 | |2 22 |1 01 |x 0018 |a h64 Springer Biomedical | ||
| 995 | |2 23 |1 01 |x 0830 |a olr-springer | ||
| 995 | |2 34 |1 01 |x 3551 |a OLR-SEB-SBL | ||
| 995 | |2 65 |1 01 |x 0003 |a OLR-SEB-ZDB-2-SBL | ||
| 995 | |2 100 |1 01 |x 3100 |a OLR-SEB | ||
| 995 | |2 101 |1 01 |x 3101 |a OLR-SEB | ||
| 995 | |2 120 |1 01 |x 0715 |a alma | ||
| 995 | |2 130 |1 01 |x 0700 |a OLR-SEB | ||
| 995 | |2 132 |1 01 |x 0959 |a OLR-ESP-SBL | ||
| 995 | |2 132 |1 01 |x 0959 |a OLR-ESP | ||
| 995 | |2 186 |1 01 |x 0519 |a OLR-SEB | ||
| 995 | |2 285 |1 01 |x 0517 |a OLR-ESP-SBL | ||
| 995 | |2 381 |1 01 |x 4381 |a OLR-SEB | ||
| 998 | |2 23 |1 01 |x 0830 |0 2023.09.08 | ||
| 998 | |2 2003 |1 01 |x DE-25 |0 05-09-23 |f 17 | ||